Associate Professor Michelle Tate is an emerging leader in the fields of viral pathogenesis and immunology. After completing her PhD studies at the University of Melbourne in 2010, Michelle was recruited to the Centre for Innate Immunity and Infectious Diseases. A/Prof Tate is currently a NHMRC Career Development Fellow and since 2017 has led the Viral Immunity and Immunopathology research group. 

A/Prof Tate’s research interests lie primarily in understanding the molecular mechanisms and pathways involved in the development of hyperinflammation and severe disease, particularly during influenza A virus infection. Critically, she has made significant contributions to understanding viral pathogenesis including the identification of new therapeutic targets and treatment strategies. A/Prof Tate’s research has been published in top virology, immunology and multidisciplinary journals such as PLoS Pathogens, Immunity, eLife, Journal of Immunology, Journal of Virology, British Journal of Pharmacology and Scientific Reports. In addition, A/Prof Tate productively collaborates with a number of commercial partners to facilitate the development of novel anti-inflammatory drugs for influenza, COVID-19, as well as respiratory diseases such as silicosis. 

In recognition of her achievements, A/Prof Tate has been awarded an NHMRC Project and Ideas Grants, an MRFF grant, as well as NHMRC Early Career and Career Development Fellowships. A/Prof Tate has received numerous national and international awards, including a Young Tall Poppy Science Award (2018), the Christina Fleischmann Memorial Award (International Cytokine and Interferon Society 2016), Victorian Infection and Immunity Network Career Development Award (2016) and a Commendation for the Victorian Premier’s Award for Health and Medical Research (2011). Her research has been acknowledged by invitations to present at international and national meetings. In addition, A/Prof Tate is a member of the Journal of Virology, Virology Journal, Pathogens and Frontiers Viral Immunology editorial boards.